The Crispr Therapeutics Market was valued at US$ 172.28 Million in 2025 and is projected to reach US$ 4771.17 Million by 2033, growing at a CAGR of 51.46% during 2026–2033. The retrieved public source material for this batch did not expose all three headline values required for a verified numerical opening, so no market-size figure or CAGR is inferred. Management should view the market as...